IMPORTANT DISCLAIMER: Blank Capital Research ("BCR") is a technology platform, not a registered investment advisor or broker-dealer. The algorithmically generated signals, scores, and rankings provided on this site ("God Mode" Signals) are for informational and research purposes only and do not constitute financial advice, investment recommendations, or an offer to sell or solicit an offer to buy any securities.
HYPOTHETICAL PERFORMANCE RESULTS: The "timing scores" and "regime signals" displayed are based on quantitative models. Hypothetical or simulated performance results have certain inherent limitations. Unlike an actual performance record, simulated results do not represent actual trading. Also, since the trades have not actually been executed, the results may have under-or-over compensated for the impact, if any, of certain market factors, such as lack of liquidity.
RISK OF LOSS: Trading in financial markets involves a high degree of risk and may result in the loss of your entire investment. Data provided by third-party sources (Intrinio, Snowflake) is believed to be reliable but is not guaranteed for accuracy or completeness. Past performance is not indicative of future results.
© 2026 Blank Capital Research. All rights reserved. System Version: Aegis V8 (God Mode).
Verdict
Quantitative factor alignment verified for current market regime.
Quant Score
Rank
#1434
Positioning
Market Dominance
Manufacturing
Computer Hardware
$1.4B
Randall A. Lipps
Omnicell, Inc., together with its subsidiaries, provides medication management solutions and adherence tools. The company offers point of care automation solutions to improve clinician workflows in patient care areas of the healthcare system. It also provides central pharmacy automation solutions, including automated storage and retrieval systems; IV compounding robots and workflow management systems.
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
| Stock | Rating | Score▼ | Quality | Value | Momentum | P/E | EV/EBITDA | ROE | ROA | Gross Mgn | Op Mgn | Net Mgn | Rev Growth | Div Yield | D/E | Mkt Cap | AUDIT |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
$UL UNILEVER PLC | 78 | 96 | 98 | 59 | - | - | 28.5% | 8.0% | 100.0% | 100.0% | 10.4% | -4.6% | 3.3% | 0.0x | $141.8B | VS | |
$ASML ASML HOLDING NV | 77 | 89 | 86 | 83 | - | - | 46.1% | 16.6% | 51.3% | 31.9% | 26.8% | -4.0% | 1.0% | 25.0x | $272.1B | VS | |
$ESLT ELBIT SYSTEMS LTD | 76 | 81 | 87 | 85 | - | - | 10.3% | 3.1% | 24.1% | 7.2% | 4.7% | 14.3% | 0.8% | 25.0x | $11.4B | VS | |
$MT ArcelorMittal | 75 | 71 | 98 | 85 | - | - | 2.2% | 1.5% | 9.3% | 5.3% | 2.2% | -8.5% | 2.2% | 16.0x | $18.9B | VS | |
$AMAT APPLIED MATERIALS INC /DE | 75 | 85 | 87 | 84 | 20.9x | 13.6x | 35.5% | 19.8% | 48.7% | 29.2% | 24.7% | 4.4% | 0.8% | 32.0x | $181.9B | VS | |
$SIMO Silicon Motion Technology CORP | 75 | 84 | 86 | 85 | - | - | 11.8% | 8.8% | 45.9% | 11.3% | 11.1% | 25.7% | 3.7% | 0.0x | $1.8B | VS | |
$CODA Coda Octopus Group, Inc. | 74 | 83 | 90 | 79 | 16.3x | 11.9x | 7.6% | 7.0% | 66.5% | 17.1% | 15.6% | 39.0% | 0.0% | 0.0x | $115M | VS | |
$GSK GSK plc | 74 | 84 | 90 | 70 | - | - | 22.6% | 4.9% | 71.2% | 12.8% | 9.4% | 1.7% | 5.9% | 124.0x | $72.1B | VS | |
$EFXT Enerflex Ltd. | 74 | 80 | 91 | 83 | - | - | 3.0% | 1.1% | 20.9% | 7.3% | 1.3% | 3.0% | 0.9% | 67.0x | $1.2B | VS | |
$BUD Anheuser-Busch InBev SA/NV | 74 | 84 | 97 | 63 | - | - | 8.2% | 3.5% | 55.3% | 25.9% | 12.4% | 0.7% | 1.7% | 0.0x | $87.0B | VS | |
$OMCL OMNICELL, INC. | 54 | 56 | 67 | 60 | 142.2x | 159.8x | 1.0% | 0.7% | 42.9% | 0.9% | 1.0% | 12.2% | 0.0% | 60.0x | $1.4B | ||
| SECTOR BENCH | - | - | - | - | - | 22.3x | 11.5x | -2.5% | -0.1% | 42.5% | 1.3% | -0.2% | 5.9% | 0.0% | 0.2x | - | REF |
OMNICELL, INC. (OMCL) receives a "Hold" rating with a composite score of 53.7/100. It ranks #1434 out of 7,333 stocks in our coverage universe and carries a 3-star rating. Ratings are driven by a 6-factor quantitative model measuring quality, value, momentum, investment, stability, and short interest.
Sign in to join the discussion.
YOY expansion rate
Core pricing power
Operating efficiency
Bottom-line conversion
Equity capital efficiency
Asset base utilization
Financial leverage load
Direct cash return
Randall A. Lipps
Chief Executive Officer
Labor Force
3,800
56
46
59
Audit Verdict: Average governance indicators based on financial metrics.
No recent insider transactions available for OMCL
In-line with peers — no strong momentum signal
Trading at a discount to fundamentals — favorable entry valuation
Average quality profile
Average volatility — neutral timing signal
Moderate investment profile
Mid-range overall rating
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
Relative valuation derived from Manufacturing sector benchmarks. Model weights: EV/EBITDA (40%), P/B (35%), P/S (25%). Re-calculated daily.
Projection based on user-defined inputs. Re-calculated daily against current market data.
Reverse DCF Framework — Mauboussin Methodology
Institutional-grade Reverse DCF analysis. This model identifies the growth hurdles embedded in current market prices. When implied growth is significantly lower than historical or projected rates, a margin of safety may exist. Re-audited daily.
No analyst ratings for OMCL.
View All RatingsConservative accounting — High cash conversion efficiency
Material decline in asset turnover efficiency detected
High margin volatility — erratic forensic earnings quality
| Factor | Global | Sector | Tilt |
|---|---|---|---|
| PROFITABILITY | 56 | 46 | +10ALPHA |
| MOMENTUM | 60 | 54 | +6ALPHA |
| VALUATION | 67 | 59 | +8ALPHA |
| INVESTMENT | 46 | 85 | -39DRAG |
| STABILITY | 59 | 48 | +11ALPHA |
| SHORT INT | 48 | 45 | +3NEUTRAL |
Global = full universe. Sector = relative to industry peers. Positive tilt indicates idiosyncratic strength.
ROE proxy 1.0% (sector -2.5%)
GM 43% vs sector 43%, OM 1% vs sector 1%
Capital turnover N/A, R&D intensity 7.6%
Rev growth 12%, 10yr history
Interest coverage N/A, Net debt/EBITDA -1.5x
Composite assessment of profitability, capital efficiency, and financial strength. Top-tier entities demonstrate sustainable cash flow generation and elite competitive moats.
Profit generated per dollar of shareholder equity
Efficiency of asset utilization
Pricing power and cost efficiency
Core business profitability
Bottom-line profitability
The Quality factor evaluates the persistence and magnitude of realized cash flows. Companies with scores >70 exhibit superior pricing power and structural financial resilience through diverse economic regimes.
Our uncertainty rating tracks the predictability of future cash flows and potential for permanent capital loss. Moderate visibility with standard industry cyclicality.
Our model assigns OMNICELL, INC. a Hold rating, with a composite score of 53.7/100 and 3 out of 5 stars. Ranked #1434 of 7,333 stocks, OMCL presents a mixed quantitative picture — neither compelling enough to initiate new positions nor weak enough to warrant selling. Investors already holding may consider maintaining their position while monitoring for changes in the factor profile.
With a quality score of 56/100, OMCL shows adequate but unremarkable business quality. The company reports a return on equity of 1.0% (sector avg: -2.5%), gross margins of 42.9% (sector avg: 42.5%), net margins of 1.0% (sector avg: -0.2%). This suggests the company generates acceptable returns but may lack the competitive positioning or operational efficiency to stand out from peers.
OMCL's value score of 67/100 indicates the stock is fairly valued based on its current fundamentals. Key valuation metrics include a P/E ratio of 142.17x, an EV/EBITDA of 159.76x, a P/B ratio of 1.48x. At this level, neither a clear bargain nor overpriced, the stock's attractiveness depends more on forward growth expectations and qualitative factors.
With an investment score of 46/100, OMCL exhibits moderate growth-oriented spending. Key growth metrics include revenue growth of 12.2% vs. a sector average of 5.9% and a return on assets of 0.7% (sector: -0.1%). The company appears to be balancing growth investments with capital returns, though the pace of investment may not be enough to accelerate top-line growth meaningfully.
OMCL demonstrates moderate momentum with a score of 60/100, suggesting a neutral price trend without strong directional conviction. Revenue growth stands at 12.2% year-over-year, while a beta of 0.97 reflects its sensitivity to broader market moves. Moderate momentum may indicate the stock is consolidating or transitioning between trends, warranting close monitoring of upcoming catalysts.
With a stability score of 59/100, OMCL exhibits average financial resilience. Key stability metrics include a beta of 0.97 and a debt-to-equity ratio of 60.00x (sector avg: 0.2x). While the balance sheet is not a major concern, the stock is subject to typical market volatility and may experience sharper drawdowns during risk-off episodes.
The short interest score of 48/100 for OMCL suggests somewhat elevated bearish positioning by institutional traders. Specific risk factors include elevated leverage (D/E: 60.00x), small-cap liquidity risk. With a $1.4B market cap (small-cap), OMNICELL, INC. may experience above-average volatility. Investors should consider whether the short thesis has merit or if it creates a potential short-squeeze opportunity.
OMNICELL, INC. is a small-cap company in the Manufacturing sector, ranked #0 of 50 in its sector (100th percentile) and #1434 of 7,333 overall (80th percentile). Key comparisons include ROE of 1.0% exceeding the -2.5% sector median and operating margins of 0.9% below the 1.3% sector average. This top-quartile standing reflects exceptional competitive strength relative to Manufacturing peers.
While OMCL currently exhibits a HOLD profile, superior opportunities exist within the MANUFACTURING sector. Our model identifies several "Strong Buy" candidates with higher quality scores and more attractive valuations among direct industry competitors.
View Top Manufacturing Alpha →Quant Factor Profile
Upgrade catalyst
Investment (46) is the limiting factor — improvement here would lift the composite score most.
EV/EBITDA 1294% ABOVE SECTOR MEDIAN
ROE 142% BELOW SECTOR MEDIAN
Gross Margin IN LINE WITH SECTOR BENCHMARKS
AUDIT DATA AS OF SEP 30, 2025 (Q2 FY2025)
We rate OMNICELL, INC. (OMCL) as a Hold with a composite score of 53.7/100 at a current price of $40.15. The stock presents a mixed quantitative picture — neither compelling enough to warrant new accumulation nor weak enough to justify selling for existing holders. Our factors are split, and the overall profile suggests patience is warranted.
The rating is primarily driven by strength in value (67th percentile) and momentum (60th percentile), which together account for the majority of the composite score. All factors score above the 40th percentile, indicating no material weakness in the quantitative profile. We assign a No Moat rating (35/100), Medium uncertainty, and Poor capital allocation.
Key items to watch: quarterly earnings execution and sector-level competitive dynamics. Any material change in these dynamics could warrant a reassessment of our rating. The moat trend is stable, which suggests the competitive landscape is stable for now.
OMNICELL, INC. holds a top-quartile position (#0 of 50) within the Manufacturing sector, based on our composite quantitative scoring across quality, value, momentum, and stability factors. The composite score of 53.7/100 places it at rank #1434 in our full 7,333-stock universe. At $1.4B in market capitalization, OMNICELL, INC. is a small-cap player in the Manufacturing space, which limits certain scale advantages but may allow for more agile strategic execution.
The outlook is moderately positive, with revenue expanding at 12% and favorable momentum (60th percentile) reflecting constructive market sentiment. The business shows steady execution, though the growth rate is below the levels typically associated with high-conviction growth stories. Momentum confirmation provides support for the current price level.
The margin cascade tells an important story: gross margins of 43% (+0.4pp vs sector) narrow to operating margins of 1% (-0.4pp vs sector) and net margins of 1.0%, yielding a gross-to-net conversion rate of 2%. The significant margin erosion from gross to net suggests elevated operating expenses, high interest costs, or other structural drags that warrant monitoring.
At a current price of $40.15, OMNICELL, INC. is trading near fair value based on current fundamentals. Our value factor score of 67/100 reflects a composite assessment across multiple valuation metrics including price-to-earnings, price-to-book, EV/EBITDA, and price-to-sales ratios relative to both sector peers and the broader market. Valuation metrics are mixed, with no strong signal of mispricing in either direction.
The stock currently trades at a P/E of 142.2x (a 539% premium to the sector median of 22.3x), EV/EBITDA of 159.8x (at a premium), P/B of 1.5x, P/S of 1.6x. The above-sector P/E multiple suggests the market is pricing in superior growth or quality, which our analysis finds only partially justified by current fundamentals.
Gross margins of 43% signal strong pricing power and brand/IP advantages — businesses with margins above 40% have historically demonstrated more resilient earnings through economic cycles.
Revenue growth of 12% confirms the business is expanding its addressable market — growth at this level typically supports multiple expansion and attracts institutional capital.
A value factor score of 67/100 suggests the market is underpricing these fundamentals, creating a potential margin of safety for new investors.
A P/E of 142.2x leaves little room for execution misses — any earnings disappointment could trigger a sharp multiple compression.
Thin net margins of 1.0% provide limited cushion against cost pressures, competitive pricing, or macroeconomic headwinds — even small changes in costs could swing the company to a loss.
We assign a Medium uncertainty rating to OMNICELL, INC.. The stock presents a balanced risk profile: elevated valuation multiple (P/E 142.2x) that leaves limited margin for error and the combination of leverage (60% D/E) and thin margins (1.0% net) amplifies downside risk. While not risk-free, the core business fundamentals are adequate to withstand moderate economic stress, and the range of potential outcomes around our fair value estimate is manageable.
Specific risk factors that inform our assessment include: elevated valuation multiple (P/E 142.2x) that leaves limited margin for error; the combination of leverage (60% D/E) and thin margins (1.0% net) amplifies downside risk. Each of these factors independently widens the distribution of potential outcomes, and in combination they create a risk profile that demands careful position sizing. The stability factor at the 59th percentile and quality factor at the 56th percentile provide a quantitative summary of the overall risk landscape.
Key risk mitigants include: healthy gross margins of 43% provide a buffer against cost pressures. These factors partially offset the identified risks and provide downside protection in adverse scenarios. On balance, the risk-reward profile is favorable for long-term investors.
We rate OMNICELL, INC.'s capital allocation as Poor. Key concerns include low returns on equity (1.0%), weak asset returns (ROA 0.7%). Exemplary capital allocators generate ROE above 20% and maintain conservative leverage — OMNICELL, INC. significantly underperforms these benchmarks, raising questions about management's ability to create shareholder value.
Investors should scrutinize management's reinvestment decisions and balance sheet trajectory before committing capital. Poor capital allocation often compounds over time: overlevered balance sheets limit strategic flexibility, while low returns on capital destroy shareholder value. We would need to see sustained improvement in profitability metrics and balance sheet discipline before considering an upgrade.
In summary, OMNICELL, INC. receives a Hold rating with a composite score of 53.7/100 (rank #1434 of 7,333). Our quantitative framework assigns a No Moat (35/100, trend: stable), Medium uncertainty, and Poor capital allocation. The average factor score across quality, value, momentum, stability, and investment is 58/100.
Our analysis supports a neutral stance on OMNICELL, INC.. While the quantitative profile is not weak enough to warrant selling, it lacks the multi-factor strength required for a buy recommendation. Existing holders should maintain positions and monitor for catalysts — either fundamental improvement or valuation compression — that would shift the risk-reward balance.
Analysis derived from Blank Capital Research quantitative terminal. For informational purposes only. No trade solicitation. Past performance not indicative of future results. Consult a qualified advisor.
We do not assign OMNICELL, INC. a meaningful economic moat, scoring 35/100 on our composite assessment. Current fundamentals do not demonstrate the kind of durable competitive advantages — such as superior returns on invested capital, margin superiority, or reinvestment efficiency — that would protect the company from competitive erosion over the long term. The highest-scoring pillar, margin superiority, reached only 12.5/20.
The strongest moat sources are margin superiority (12.5/20) and financial resilience (8.7/20). GM 43% vs sector 43%, OM 1% vs sector 1%. Interest coverage N/A, Net debt/EBITDA -1.5x. These pillars form the core of OMNICELL, INC.'s competitive identity and are the primary drivers of excess returns in our framework.
Areas of relative weakness include reinvestment efficiency (2.7/20) and economic value creation (3/20). Capital turnover N/A, R&D intensity 7.6%. Improvement in these areas could meaningfully widen the moat over time, while deterioration would be an early warning of competitive erosion.
Our moat trend assessment is Stable. Multi-year ROIC and operating margin trajectories show neither meaningful improvement nor deterioration, suggesting the competitive position is steady. We expect OMNICELL, INC.'s moat profile to remain largely unchanged absent a material shift in return on capital or industry dynamics.
Key profit drivers include gross margins of 43% providing a solid profitability foundation, moderate revenue growth of 12%. The margin cascade from 43% gross to 1% operating to 1.0% net reveals the company's cost structure and reinvestment intensity. Our analysis indicates that profit quality is adequate though not exceptional, with the quality factor at the 56th percentile.
The margin profile shows gross margins of 43%, operating margins of 1%, net margins of 1.0%. Return metrics include ROE of 1.0% and ROA of 0.7%. Relative to the Manufacturing sector, gross margins are 0.4 percentage points above the sector median of 43%, and ROE of 1.0% compares to a sector median of -2.5%.
The balance sheet reflects moderate leverage with D/E of 60%, revenue growth of 12%. The sector median D/E is 0%, putting OMNICELL, INC. at higher leverage than the typical peer. Overall balance sheet health is adequate for the current business environment.
Above 50MA
37.18%
Net New Highs
+51081
In early February 2026, Omnicell reported fourth-quarter 2025 revenue of US$313.98 million with a small net loss of US$2.03 million, and issued first-quarter 2026 revenue guidance of US$300 million to US$310 million plus full-year 2026 guidance of US$1.22 billion to US$1.26 billion. The results highlighted pressure on profitability despite revenue growth, even as management pointed to strong demand for XT S10 devices and a multi-year Titan XT refresh opportunity exceeding US$2.50 billion. We...
The Omnicell, Inc. ( NASDAQ:OMCL ) share price has softened a substantial 26% over the previous 30 days, handing back...

A robust Advanced Services portfolio and strategic restructuring initiatives bode well for Omnicell (OMCL).

Omnicell's EVP & Chief Legal/Admin Officer Corey Manley sold 6,106 shares worth $243,629 on December 3, 2025, reducing his direct holdings by 5.85%. The sale occurred as the stock approached 52-week highs following strong Q3 results and the announcement of the company's new Titan XT automated dispensing system, which prompted analyst upgrades.

Inspire (INSP) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.